Business Pivot – Talk Bio

Actionable Insights Powered by AI

Biogen Retains Biosimilars as Eisai-Partnered Leqembi Advances Amid Business Shift

Biogen, biosimilars, Leqembi, Eisai, Alzheimer’s disease, business pivot, pharmaceuticals, biotechnology